Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Prostate Specific Membrane Antigen (PSMA) PET Scan more accurately locates cancerous cells and tumors, improving targeted treatments.
The patient-driven Metastatic Prostate Cancer Research Project releases its first report.
Daniel Zeller, who blogs about his prostate cancer experiences, shares study findings that could be relevant to other cancers.
About 268,490 people will be diagnosed with prostate cancer this year in the United States. Here’s how you can get better informed.
CU Cancer Center researchers aim to target a mitochondrial protein overexpressed in metastatic prostate cancer.
Defining one of cancer’s most common and intimidating terms
A large clinical trial found that adding darolutamide to two other therapies increased survival for people with advanced prostate cancer.
Study confirms that Black men are at higher risk for prostate cancer disease progression and death.
Black men had “a significantly higher incidence” of both localized and metastatic prostate cancer. But researchers reported good news too.
Episode 20 with Daniel P. Petrylak, MD, Professor of Medicine (Medical Oncology) and of Urology
The third and final installment of Dr. Kwon’s educational video series.
In my previous post, I mentioned that Dr. Kwon was a pioneer in dealing with oligometastatic prostate cancer.
P-NET is a “biologically informed deep learning model” capable of guessing a prostate cancer patient’s disease state.
Adding Zytiga plus prednisolone to standard therapy lengthened survival.
A cancer therapy that delivers radiation directly to cancer cells may represent the newest advance in the treatment of prostate cancer.
Men at high risk for death from prostate cancer had a significant reduction in mortality if treated with radiation shortly after surgery.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.